Neoplasms, Hematologic Completed Phase 1 Trials for SNX-5422 (DB06070)

Also known as: Hematological Neoplasm / Hematological Neoplasms / Hematologic Neoplasm / Hematologic Neoplasms / Haematological neoplasm / Malignant tumor of lymphoid hemopoietic and related tissue (disorder) / Haematological malignancy / Hematological malignancy / Hematologic neoplasm (disorder)

IndicationStatusPhase
DBCOND0056760 (Neoplasms, Hematologic)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00595686Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological MalignanciesTreatment